Skip to main content
U.S. flag

An official website of the United States government

Bill G. Kapogiannis, M.D.

Bill G. Kapogiannis, M.D.Bill G. Kapogiannis, M.D. (Acting)
March 2023–December 2023

Bill G. Kapogiannis, M.D., FIDSA, served as Acting Associate Director of AIDS Research and Acting Director of OAR from March to December 2023. Effective December 17, 2023, Dr. Kapogiannis to a new role in the Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS).

During his tenure at OAR, Dr. Kapogiannis emphasized the need to address HIV-related health disparities as a critical priority, a legacy of his prior work at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). In addition, Dr. Kapogiannis laid the foundation for development of the next NIH Strategic Plan for HIV and HIV-Related Research, revisiting the NIH HIV research priorities and streamlining the OAR planning process. He also played a central role in facilitating interagency coordination of research activities and services related to HIV and aging. 

Dr. Kapogiannis joined OAR from NICHD, where he led the Adolescent Medicine Trials Network for HIV/AIDS Interventions, a multicenter U.S.-based research program that evaluates interventions for treatment and management of HIV infection and its complications among youth, as well as for the prevention of HIV transmission in the adolescent population, including HIV vaccine, microbicide, and pre-exposure prophylaxis (PrEP) studies. At NICHD, Dr. Kapogiannis served as the scientific director of the Prevention and Treatment through a Comprehensive Care Continuum for HIV-Affected Adolescents in Resource-Constrained Settings Consortium, which conducts clinical research at the individual, family, community, structural and education, and health systems levels to improve health outcomes among adolescents with or at risk for HIV. Dr. Kapogiannis created and directed the NIH RADx-rad PreVAIL Kids Program, which is developing cutting-edge approaches for understanding factors influencing the spectrum of conditions in children infected with SARS-CoV-2. He co-directed the pediatric cohort of NIH RECOVER, which aims to understand and address long-COVID in children, adolescents, and young adults.

A board-certified infectious disease specialist in pediatrics and internal medicine, Dr. Kapogiannis earned his M.D. from the University of Illinois at Chicago College of Medicine, where he completed his residency in internal medicine/pediatrics. He completed a combined fellowship in infectious diseases in internal medicine and pediatrics at Emory University School of Medicine in Atlanta, Georgia.

This page last reviewed on December 18, 2023